Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock and Warrants
-
Maxim Group Starts Ritter Pharmaceuticals (RTTR) at Buy, $7 PT
-
Maxim Group Downgrades Domino's Pizza (DPZ) to Hold
-
PlacementTracker Publishes Q1 2016 PIPE Market League Tables
-
Juno's (JUNO) New Company Brings First Mover Advantage to China - Maxim
-
Viking Therapeutics (VKTX) Prices Common Stock and Warrant Offering for Proceeds of $9.38M
-
Viking Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
-
Maxim Group Assumes Biostage (BSTG) at Buy, $8 PT
-
Cytori Therapeutics (CYTX) Discloses $11M Rights Offering
-
Galmed Pharma (GLMD) Surges 38%
-
Starboard's Jeff Smith resigns as Darden chairman
-
Streetinsider.com's Hot Lunchtime Reads 4/4: (ESI) (AAPL) (RKUS) (GLMD)
-
Galmed Pharma (GLMD) May Be Worth $24/Share Based on Gilead's Nimbus Deal - Maxim Group
-
BioPharmX Corporation Announces Closing Of $4.3 Million Public Offering
-
Maxim Group Starts County Bancorp (ICBK) at Buy
-
RiceBran Technologies President and CEO to be a Featured Panelist at the Health, Wellness & Better Eating Conference
-
Chris Reed to Speak on Panel at the Maxim Group Health, Wellness & Better Eating Conference
-
Keryx Biopharmaceuticals (KERX) PT Rasied to $7 at Maxim Group Following Positive Study
-
BioPharmX (BPMX) Prices $4.3M Common Stock, Warrants Offering
-
BioPharmX Corporation Announces Pricing Of Public Offering To Raise $4.3 Million
-
Maxim Group Raises Price Target on Adamis Pharmaceuticals (ADMP) Following Announced US Compounding Acquisition
-
BioPharmX (BPMX) Plans Common Stock, Warrants Offering
-
BioPharmX Corporation Announces Proposed Public Offering of Common Stock and Warrants
-
Quantum Genomics Raises €8.6 Million in U.S. and Europe
-
Maxim Group Downgrades Chipotle Mexican Grill (CMG) to Sell
-
ContraFect (CFRX) PT Trimmed to $7 at Maxim Group as Results Awaited
-
GEF Acquisition Corporation Files Registration Statement for Initial Public Offering
-
StemCells, Inc. Announces Closing of $8 Million Public Offering
-
Intec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
Maxim Group Upgrades Agenus Inc. (AGEN) to Buy
-
Pre-Open Stock Movers 03/11 (SSKN) (FNSR) (ULTA) Higher; (FXCM) (SGY) (RUN) Lower (more...)
-
Athersys (ATHX) PT Doubled to $10 at Maxim Group
-
StemCells (STEM) Prices $11M Stock, Warrants Offering
-
StemCells, Inc. Announces Pricing of Public Offering to Raise $8.1 Million
-
Maxim Group Starts Determine (DTRM) at Buy
-
StemCells (STEM) to Offer Common Stock and Warrants
-
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
The Alliance for Regenerative Medicine Releases Agenda for Fourth Annual Cell & Gene Therapy Investor Day
-
Jensyn Acquisition Corporation Completes $39.0 Million Initial Public Offering
-
UPDATE: Maxim Group Downgrades NovaBay Pharmaceuticals (NBY) to Hold
-
Dunkin' Donuts to target Starbucks customers after loyalty scheme shake-up
-
Jensyn Acquisition Corp. Announces Pricing of Initial Public Offering
-
Maxim Group Downgrades Benitec BioPharma (BNTC) to Hold
-
Domino's profit boosted as demand holds up in U.S. pizza price war
-
root9B Technologies Receives $1.26 Million In Proceeds From Warrant Exercise Offer
-
RiceBran Technologies Announces Closing of $3 Million Registered Direct Offering
-
Notable Mergers and Acquisitions 2/22: (SYY) (PHMD)/(DSKX) (VZ)
-
PhotoMedex (PHMD) Announces Agreement to Sell Consumer Products, Professional Products Businesses to DS Healthcare (DSKX)
-
DS Healthcare (DSKX) to Acquire Radiancy from PhotoMedex
-
DS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology Businesses

